Warsaw, Ind.-based OrthoPediatrics reported preliminary unaudited third quarter 2025 net revenue of about $61.2 million, according to an Oct. 9 news release from the company.
Here are four more financial notes:
- Third quarter revenue in 2025 grew 12% compared to the third quarter of 2024, when the company brought in $54.6 million.
- Domestic revenue is expected to be about $48.7 million and international revenue is projected to be about $12.5 million for the third quarter.
- For the full year of 2025, OrthoPediatrics is expecting revenue between $233.5 million and $234.5 million.
- If the projection is accurate, the company’s 2025 revenue would be 14% to 15% higher than 2024.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.